GO Term	Description	P-value	FDR q-value	Enrichment	N	B	n	b	Genes
GO:0010595	positive regulation of endothelial cell migration	8.85E-7	5.76E-3	7.26	679	11	68	8	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, MET  -  met proto-oncogene, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1]
GO:0006928	movement of cell or subcellular component	1.42E-6	4.61E-3	2.50	679	100	68	25	[DST  -  dystonin, DOCK4  -  dedicator of cytokinesis 4, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, DPYSL2  -  dihydropyrimidinase-like 2, ADCY3  -  adenylate cyclase 3, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, EXT1  -  exostosin glycosyltransferase 1, SDC2  -  syndecan 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, MYO5C  -  myosin vc, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, MYO5A  -  myosin va (heavy chain 12, myoxin), MYO1E  -  myosin ie, FAT1  -  fat atypical cadherin 1, LAMB1  -  laminin, beta 1]
GO:0010594	regulation of endothelial cell migration	1.87E-6	4.07E-3	5.99	679	15	68	9	[NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, MET  -  met proto-oncogene]
GO:0010634	positive regulation of epithelial cell migration	2.48E-5	4.03E-2	5.33	679	15	68	8	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, MET  -  met proto-oncogene]
GO:0030335	positive regulation of cell migration	3.71E-5	4.84E-2	3.79	679	29	68	11	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:2000147	positive regulation of cell motility	3.71E-5	4.03E-2	3.79	679	29	68	11	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:0030198	extracellular matrix organization	3.97E-5	3.69E-2	5.82	679	12	68	7	[PXDN  -  peroxidasin homolog (drosophila), ST7  -  suppression of tumorigenicity 7, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MYO1E  -  myosin ie, EXT1  -  exostosin glycosyltransferase 1, LAMB1  -  laminin, beta 1]
GO:1900046	regulation of hemostasis	4.87E-5	3.96E-2	8.32	679	6	68	5	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, EPHB2  -  eph receptor b2, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha]
GO:0030193	regulation of blood coagulation	4.87E-5	3.52E-2	8.32	679	6	68	5	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha]
GO:0050818	regulation of coagulation	4.87E-5	3.17E-2	8.32	679	6	68	5	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha]
GO:0040017	positive regulation of locomotion	5.4E-5	3.2E-2	3.66	679	30	68	11	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:0051272	positive regulation of cellular component movement	5.4E-5	2.93E-2	3.66	679	30	68	11	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:0010632	regulation of epithelial cell migration	6.69E-5	3.35E-2	4.28	679	21	68	9	[NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, MET  -  met proto-oncogene]
GO:0043062	extracellular structure organization	7.91E-5	3.68E-2	5.38	679	13	68	7	[PXDN  -  peroxidasin homolog (drosophila), ST7  -  suppression of tumorigenicity 7, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MYO1E  -  myosin ie, EXT1  -  exostosin glycosyltransferase 1, LAMB1  -  laminin, beta 1]
GO:0043536	positive regulation of blood vessel endothelial cell migration	9.28E-5	4.03E-2	9.99	679	4	68	4	[THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:1904018	positive regulation of vasculature development	1.24E-4	5.06E-2	5.99	679	10	68	6	[THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0045766	positive regulation of angiogenesis	1.24E-4	4.76E-2	5.99	679	10	68	6	[SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:0080134	regulation of response to stress	1.34E-4	4.85E-2	2.31	679	82	68	19	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, PLAUR  -  plasminogen activator, urokinase receptor, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, NUAK1  -  nuak family, snf1-like kinase, 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), RNF135  -  ring finger protein 135]
GO:0050678	regulation of epithelial cell proliferation	2.26E-4	7.75E-2	3.44	679	29	68	10	[VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, NFIB  -  nuclear factor i/b, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), PRKCA  -  protein kinase c, alpha, GPX1  -  glutathione peroxidase 1, LAMB1  -  laminin, beta 1]
GO:0061041	regulation of wound healing	2.51E-4	8.19E-2	4.66	679	15	68	7	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha]
GO:1903034	regulation of response to wounding	2.51E-4	7.8E-2	4.66	679	15	68	7	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha]
GO:0001817	regulation of cytokine production	3.61E-4	1.07E-1	3.05	679	36	68	11	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), RNF135  -  ring finger protein 135]
GO:0043535	regulation of blood vessel endothelial cell migration	3.86E-4	1.09E-1	6.24	679	8	68	5	[MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:0002715	regulation of natural killer cell mediated immunity	4.29E-4	1.16E-1	7.99	679	5	68	4	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0032655	regulation of interleukin-12 production	4.29E-4	1.12E-1	7.99	679	5	68	4	[HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, FOXP1  -  forkhead box p1]
GO:0042269	regulation of natural killer cell mediated cytotoxicity	4.29E-4	1.07E-1	7.99	679	5	68	4	[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0097435	supramolecular fiber organization	4.7E-4	1.13E-1	3.46	679	26	68	9	[PXDN  -  peroxidasin homolog (drosophila), DST  -  dystonin, MYO5C  -  myosin vc, MYO5A  -  myosin va (heavy chain 12, myoxin), MYO1E  -  myosin ie, KATNAL1  -  katanin p60 subunit a-like 1, DPYSL3  -  dihydropyrimidinase-like 3, EXT1  -  exostosin glycosyltransferase 1, FAT1  -  fat atypical cadherin 1]
GO:0048870	cell motility	4.94E-4	1.15E-1	2.42	679	62	68	15	[DST  -  dystonin, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, EXT1  -  exostosin glycosyltransferase 1, NRP2  -  neuropilin 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, MEF2C  -  myocyte enhancer factor 2c, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, FAT1  -  fat atypical cadherin 1, ADCY3  -  adenylate cyclase 3, LAMB1  -  laminin, beta 1]
GO:0030334	regulation of cell migration	5.93E-4	1.33E-1	2.60	679	50	68	13	[DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, DPYSL3  -  dihydropyrimidinase-like 3, LAMB1  -  laminin, beta 1]
GO:0040011	locomotion	6.25E-4	1.36E-1	2.28	679	70	68	16	[DST  -  dystonin, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, EXT1  -  exostosin glycosyltransferase 1, NRP2  -  neuropilin 2, PLAUR  -  plasminogen activator, urokinase receptor, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, MEF2C  -  myocyte enhancer factor 2c, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, FAT1  -  fat atypical cadherin 1, ADCY3  -  adenylate cyclase 3, LAMB1  -  laminin, beta 1]
GO:0045765	regulation of angiogenesis	6.44E-4	1.35E-1	4.11	679	17	68	7	[HLA-G  -  major histocompatibility complex, class i, g, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:1901342	regulation of vasculature development	6.44E-4	1.31E-1	4.11	679	17	68	7	[HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0001819	positive regulation of cytokine production	6.48E-4	1.28E-1	3.33	679	27	68	9	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), RNF135  -  ring finger protein 135]
GO:0050878	regulation of body fluid levels	6.89E-4	1.32E-1	3.63	679	22	68	8	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, MET  -  met proto-oncogene, EXT1  -  exostosin glycosyltransferase 1, ADCY3  -  adenylate cyclase 3]
GO:2000145	regulation of cell motility	7.32E-4	1.36E-1	2.55	679	51	68	13	[DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, DPYSL3  -  dihydropyrimidinase-like 3, LAMB1  -  laminin, beta 1]
GO:0002699	positive regulation of immune effector process	7.94E-4	1.44E-1	4.61	679	13	68	6	[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1]
GO:0014910	regulation of smooth muscle cell migration	9.65E-4	1.7E-1	9.99	679	3	68	3	[MEF2C  -  myocyte enhancer factor 2c, DOCK4  -  dedicator of cytokinesis 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1]
GO:0002062	chondrocyte differentiation	9.65E-4	1.65E-1	9.99	679	3	68	3	[NFIB  -  nuclear factor i/b, MEF2C  -  myocyte enhancer factor 2c, EXT1  -  exostosin glycosyltransferase 1]
GO:0002480	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	9.65E-4	1.61E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	9.65E-4	1.57E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0002718	regulation of cytokine production involved in immune response	9.65E-4	1.53E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-G  -  major histocompatibility complex, class i, g]
GO:0002716	negative regulation of natural killer cell mediated immunity	9.65E-4	1.5E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0002720	positive regulation of cytokine production involved in immune response	9.65E-4	1.46E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-G  -  major histocompatibility complex, class i, g]
GO:0045953	negative regulation of natural killer cell mediated cytotoxicity	9.65E-4	1.43E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I	9.65E-4	1.4E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:1903670	regulation of sprouting angiogenesis	9.65E-4	1.37E-1	9.99	679	3	68	3	[THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0042270	protection from natural killer cell mediated cytotoxicity	9.65E-4	1.34E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0090049	regulation of cell migration involved in sprouting angiogenesis	9.65E-4	1.31E-1	9.99	679	3	68	3	[THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0060337	type I interferon signaling pathway	9.65E-4	1.28E-1	9.99	679	3	68	3	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0097485	neuron projection guidance	9.72E-4	1.27E-1	3.47	679	23	68	8	[NFIB  -  nuclear factor i/b, NRP2  -  neuropilin 2, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, DPYSL2  -  dihydropyrimidinase-like 2, EXT1  -  exostosin glycosyltransferase 1, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0007411	axon guidance	9.72E-4	1.24E-1	3.47	679	23	68	8	[NFIB  -  nuclear factor i/b, NRP2  -  neuropilin 2, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, DPYSL2  -  dihydropyrimidinase-like 2, EXT1  -  exostosin glycosyltransferase 1, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
